Physician profile
Florence Smith
NPI 1811424419
$2,648.06
in general payments reported to CMS, 2019-2025
31 companies · $665 in 2025
The $665 reported for 2025 was more than what 78% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $339 · 2023: $720 · 2024: $693 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $444.78 | 2023-2025 | |
| Lilly USA, LLC | $354.44 | 2021-2025 | Kisunla, Amyvid |
| Otsuka America Pharmaceutical, INC. | $307.80 | 2023-2025 | Rexulti, Nuedexta |
| Pfizer INC. | $258.02 | 2021-2025 | |
| Ge Healthcare | $232.18 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $138.73 | 2022-2023 | |
| Mylan Specialty L.P. | $132.80 | 2021-2024 | Yupelri |
| Viatris Specialty LLC | $107.86 | 2025 | Yupelri |
| Lundbeck LLC | $101.61 | 2023-2025 | Rexulti |
| Abbvie INC. | $47.53 | 2022-2025 | |
| Amgen INC. | $43.95 | 2021-2022 | |
| Exact Sciences Corporation | $43.44 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Avanir Pharmaceuticals, INC. | $43.12 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $41.79 | 2021-2022 | |
| Dexcom, INC. | $37.67 | 2022-2023 | Dexcom G6 Transmitter |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $37.31 | 2024 | |
| Insmed, INC. | $31.98 | 2024-2025 | Arikayce, Brinsupri |
| Biogen, INC. | $30.23 | 2021-2025 | Leqembi |
| Nestle Healthcare Nutrition INC. | $28.62 | 2022 | |
| Tempus Ai, INC | $26.09 | 2024 | |
| Aimmune Therapeutics, INC. | $16.77 | 2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.83 | 2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $15.29 | 2023 | Vpriv |
| Merck Sharp & Dohme LLC | $14.93 | 2025 | Capvaxive |
| Astellas Pharma US INC | $14.45 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.40 | 2022 | |
| Acadia Pharmaceuticals INC | $14.16 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.85 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.83 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.42 | 2022 | |
| Alfasigma USA, INC. | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florence Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.